Integrated environmental and clinical surveillance for the prevention of acute respiratory infections (ARIs) in indoor environments and vulnerable communities (Stell-ARI): Protocol.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 04 03 2024
accepted: 06 08 2024
medline: 30 9 2024
pubmed: 30 9 2024
entrez: 30 9 2024
Statut: epublish

Résumé

The epidemiological relevance of viral acute respiratory infections (ARIs) has been dramatically highlighted by COVID-19. However, other viruses cannot be neglected, such as influenza virus, respiratory syncytial virus, human adenovirus. These viruses thrive in closed spaces, influenced by human and environmental factors. High-risk closed communities are the most vulnerable settings, where the real extent of viral ARIs is often difficult to evaluate, due to the natural disease progression and case identification complexities. During the COVID-19 pandemic, wastewater-based epidemiology has demonstrated its great potential for monitoring the circulation and evolution of the virus in the environment. The "Prevention of ARIs in indoor environments and vulnerable communities" study (Stell-ARI) addresses the urgent need for integrated surveillance and early detection of ARIs within enclosed and vulnerable communities such as long-term care facilities, prisons and primary schools. The rapid transmission of ARIs in such environments underscores the importance of comprehensive surveillance strategies to minimise the risk of outbreaks and safeguard community health, enabling proactive prevention and control strategies to protect the health of vulnerable populations. This study consists of designing and validating tools for integrated clinical and environmental-based surveillance for each setting, coupled with analytical methods for environmental matrices. The clinical surveillance involves specialized questionnaires and nasopharyngeal swabs for virus identification, while the environmental surveillance includes air and surface microbiological and chemical monitoring, and virological analysis of wastewater. Integrating this information and the collection of behavioural and environmental risk factors into predictive and risk assessment models will provide a useful tool for early warning, risk assessment and informed decision-making. The study aims to integrate clinical, behavioural, and environmental data to establish and validate a predictive model and risk assessment tool for the early warning and risk management of viral ARIs in closed and vulnerable communities prior to the onset of an outbreak.

Identifiants

pubmed: 39348341
doi: 10.1371/journal.pone.0309111
pii: PONE-D-24-08261
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0309111

Informations de copyright

Copyright: © 2024 Carducci et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Annalaura Carducci (A)

Hygiene and Environmental Virology, Department of Biology, University of Pisa, Pisa, Italy.

Guglielmo Arzilli (G)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Nebiyu Tariku Atomsa (NT)

Hygiene and Environmental Virology, Department of Biology, University of Pisa, Pisa, Italy.

Giulia Lauretani (G)

Hygiene and Environmental Virology, Department of Biology, University of Pisa, Pisa, Italy.

Marco Verani (M)

Hygiene and Environmental Virology, Department of Biology, University of Pisa, Pisa, Italy.

Francesco Pistelli (F)

Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.

Lara Tavoschi (L)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Ileana Federigi (I)

Hygiene and Environmental Virology, Department of Biology, University of Pisa, Pisa, Italy.

Marco Fornili (M)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Davide Petri (D)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Tommaso Lomonaco (T)

Department of Chemistry and Industrial Chemistry, University of Pisa, Pisa, Italy.

Claudia Meschi (C)

Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.

Alessandra Pagani (A)

Hygiene and Environmental Virology, Department of Biology, University of Pisa, Pisa, Italy.

Antonello Agostini (A)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Laura Carrozzi (L)

Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.

Laura Baglietto (L)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Daniela Paolotti (D)

Italian Institute for Scientific Interchange, ISI Foundation, Turin, Italy.

Ciro Cattuto (C)

Italian Institute for Scientific Interchange, ISI Foundation, Turin, Italy.

Lorenzo Dall'Amico (L)

Italian Institute for Scientific Interchange, ISI Foundation, Turin, Italy.

Caterina Rizzo (C)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH